Custom RNA oligos in support of covid-19 research
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00410
- Awardee
-
Bio-Synthesis, Inc. UEI MWJBT69QFLH4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $28,135
Award facts
- Opportunity
-
- Acquisition of custom RNA oligos in support of COVID-19 research Solicitation · 75N95022Q00358 · Posted Jul 11, 2022
- Contract value 100% obligated
- $28,135.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Lewisville, TX 75057, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $28,135 |
Quick answers
Who was awarded contract 75N95022P00410?
75N95022P00410 was awarded to Bio-Synthesis, Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 5, 2022.
How much is contract 75N95022P00410 worth?
The government has obligated $28,135 on 75N95022P00410.
Was contract 75N95022P00410 competed?
The extent of competition for 75N95022P00410 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award